Case report: Successful use of mepolizumab for immune checkpoint inhibitors-induced hypereosinophilic syndrome in two patients with solid malignancies.
Front Oncol
; 13: 1079034, 2023.
Article
in En
| MEDLINE
| ID: mdl-36776300
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Front Oncol
Year:
2023
Document type:
Article
Affiliation country:
Italy
Country of publication:
Switzerland